Related content

Survival and prognostic factors after moderately hypofractionated palliative thoracic radiotherapy for non-small cell lung cancer

By Oorschot B.   Assenbrunner B.   Schuler M.   Beckmann G.   Flentje M.  

Strahlentherapie und Onkologie, Vol. 190, Iss. 3, 2014-03 ,pp. : 270-275

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Impact of VEGF and VEGF Receptor 1 (FLT1) Expression in Patients Irradiated for Stage II/III Non-Small Cell Lung Cancer (NSCLC)

By Rades Dirk   Setter Cornelia   Dunst Juergen   Dahl Olav   Schild Steven   Noack Frank  

Strahlentherapie und Onkologie, Vol. 186, Iss. 6, 2010-06 ,pp. : 307-314

Springer Publishing Company

Access to resources Recommend Favorite

Toxicity and dosimetric analysis of non–small cell lung cancer patients undergoing radiotherapy with 4DCT and image‐guided intensity modulated radiotherapy: a regional centre's experience

By  

Journal Of Medical Radiation Sciences, Vol. 63, Iss. 3, 2016-09 ,pp. : 170-178

John Wiley & Sons Inc

Access to resources Recommend Favorite

Volume-based assessment by ¹⁸F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer

By Hyun Seung   Ahn Hee   Kim Hojoong   Ahn Myung-Ju   Park Keunchil   Ahn Yong   Kim Jhingook   Shim Young   Choi Joon  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 41, Iss. 1, 2014-01 ,pp. : 50-58

Springer Publishing Company

Access to resources Recommend Favorite

Brain metastasis from non-small cell lung cancer (NSCLC): Prognostic importance of the number of involved extracranial organs

By Gerdan L.   Segedin B.   Nagy V.   Khoa M.T.   Trang N.T.   Schild S.E.   Rades D.  

Strahlentherapie und Onkologie, Vol. 190, Iss. 1, 2014-01 ,pp. : 64-67

Springer Publishing Company

Access to resources Recommend Favorite